These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11472372)

  • 1. Reduced serum ceruloplasmin levels in hereditary haemochromatosis.
    Cairo G; Conte D; Bianchi L; Fraquelli M; Recalcati S
    Br J Haematol; 2001 Jul; 114(1):226-9. PubMed ID: 11472372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis.
    Kelleher T; Ryan E; Barrett S; Sweeney M; Byrnes V; O'Keane C; Crowe J
    Gut; 2004 Aug; 53(8):1174-9. PubMed ID: 15247188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rare, but important chronic liver diseases].
    Maier KP
    Praxis (Bern 1994); 2002 Nov; 91(48):2077-85. PubMed ID: 12508671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes.
    de Valk B; Addicks MA; Gosriwatana I; Lu S; Hider RC; Marx JJ
    Eur J Clin Invest; 2000 Mar; 30(3):248-51. PubMed ID: 10692002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: the HEmochromatosis FAmily Study.
    Jacobs EM; Hendriks JC; van Deursen CT; Kreeftenberg HG; de Vries RA; Marx JJ; Stalenhoef AF; Verbeek AL; Swinkels DW
    J Hepatol; 2009 Jan; 50(1):174-83. PubMed ID: 19008010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of iron overload on glucose metabolism in patients with hereditary hemochromatosis.
    Hatunic M; Finucane FM; Brennan AM; Norris S; Pacini G; Nolan JJ
    Metabolism; 2010 Mar; 59(3):380-4. PubMed ID: 19815242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of HFE Haemochromatosis in the clinic and community using standard erythrocyte tests.
    Adris N; Hazeldine S; Bentley P; Trinder D; Chua ACG; Powell LW; Ramm LE; Ramm GA; Olynyk JK
    Blood Cells Mol Dis; 2019 Feb; 74():18-24. PubMed ID: 30340937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis.
    Casanova-Esteban P; Guiral N; Andrés E; Gonzalvo C; Mateo-Gallego R; Giraldo P; Paramo JA; Civeira F
    Metabolism; 2011 Jun; 60(6):830-4. PubMed ID: 20846699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic study of variation in normal mouse iron homeostasis reveals ceruloplasmin as an HFE-hemochromatosis modifier gene.
    Gouya L; Muzeau F; Robreau AM; Letteron P; Couchi E; Lyoumi S; Deybach JC; Puy H; Fleming R; Demant P; Beaumont C; Grandchamp B
    Gastroenterology; 2007 Feb; 132(2):679-86. PubMed ID: 17258727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis.
    Abraham D; Rogers J; Gault P; Kushner JP; McClain DA
    Diabetologia; 2006 Nov; 49(11):2546-51. PubMed ID: 17019598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women.
    Roe MA; Spinks C; Heath AL; Harvey LJ; Foxall R; Wimperis J; Wolf C; Fairweather-Tait SJ
    Br J Nutr; 2007 Mar; 97(3):544-9. PubMed ID: 17313717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum ceruloplasmin and ferroxidase activity are decreased in HFE C282Y homozygote male iron-overloaded patients.
    Lainé F; Ropert M; Lan CL; Loréal O; Bellissant E; Jard C; Pouchard M; Le Treut A; Brissot P
    J Hepatol; 2002 Jan; 36(1):60-5. PubMed ID: 11804665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload.
    Townsend A; Drakesmith H
    Lancet; 2002 Mar; 359(9308):786-90. PubMed ID: 11888608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemochromatosis: a clinical update for the practising physician.
    Radford-Smith DE; Powell EE; Powell LW
    Intern Med J; 2018 May; 48(5):509-516. PubMed ID: 29722188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive factors of response to erytrhocytapheresis in patients with biochemical iron overload with or without hereditary hemochromatosis type 1].
    Parra Salinas I; Montes Limon A; Recasens Flores V; Fernandez-Mosteirin N; Garcia-Erce JA
    Med Clin (Barc); 2014 Mar; 142(5):187-91. PubMed ID: 24041941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in HFE causing hemochromatosis are associated with primary hypertriglyceridemia.
    Solanas-Barca M; Mateo-Gallego R; Calmarza P; Jarauta E; Bea AM; Cenarro A; Civeira F
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4391-7. PubMed ID: 19820015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary hemochromatosis: missed diagnosis or misdiagnosis?
    Cherfane CE; Hollenbeck RD; Go J; Brown KE
    Am J Med; 2013 Nov; 126(11):1010-5. PubMed ID: 24054178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly sensitivity adhesion molecules detection in hereditary haemochromatosis patients reveals altered expression.
    Norris S; White M; Mankan AK; Lawless MW
    Int J Immunogenet; 2010 Apr; 37(2):125-33. PubMed ID: 20193033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
    Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
    Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased capacity of lymphocytes from hereditary hemochromatosis patients homozygous for the C282Y HFE mutation to respond to the genotoxic effect of diepoxybutane.
    Porto B; Vieira R; Porto G
    Mutat Res; 2009 Feb; 673(1):37-42. PubMed ID: 19146986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.